Cargando…

Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?

The aim of this exploratory study was to evaluate the influence of hepatic steatosis on the detection rate of metastases in gadoxetic acid-enhanced liver magnetic resonance imaging (MRI). A total of 50 patients who underwent gadoxetic acid-enhanced MRI (unenhanced T1w in- and opposed-phase, T2w fat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffen, Ingo G., Weissmann, Thomas, Rothe, Jan Holger, Geisel, Dominik, Chopra, Sascha S., Kahn, Johannes, Hamm, Bernd, Denecke, Timm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796028/ https://www.ncbi.nlm.nih.gov/pubmed/33396634 http://dx.doi.org/10.3390/jcm10010098

Ejemplares similares

Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRI
por: Stief, Jonas D., et al.
Publicado: (2019)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2020)

Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2021)

A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI
por: Elkilany, Aboelyazid, et al.
Publicado: (2021)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
por: Plaikner, M., et al.
Publicado: (2018)

Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI
por: van Kessel, C. S., et al.
Publicado: (2012)

Performance survey on a new standardized formula for oral signal suppression in MRCP
por: Frisch, Anne, et al.
Publicado: (2017)

Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors
por: Ryeom, Hunkyu, et al.
Publicado: (2023)

Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases
por: Zech, C J, et al.
Publicado: (2014)

A Case of Hyperintense Liver Metastases of Breast Cancer in the Hepatobiliary Phase on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
por: Yamaguchi, Tomoyuki, et al.
Publicado: (2020)

HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI
por: Auer, Timo Alexander, et al.
Publicado: (2021)

Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI
por: Park, Hyo Jung, et al.
Publicado: (2022)

Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2019)

MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
por: Collettini, Federico, et al.
Publicado: (2022)

Feasibility of gadoxetate disodium enhanced 3D T1 MR cholangiography (MRC) with a specific inversion recovery prepulse for the assessment of the hepatobiliary system
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2018)

Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment
por: Tamura, Yosuke, et al.
Publicado: (2023)

Impact of Doppler Ultrasound on Diagnosis and Therapy Control of Lienalis Steal Syndrome After Liver Transplantation
por: Teegen, Eva M., et al.
Publicado: (2017)

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
por: Jeong, Woo Kyoung, et al.
Publicado: (2013)

Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function
por: Rassam, F., et al.
Publicado: (2019)

MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging
por: Moosavi, Bardia, et al.
Publicado: (2020)

Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Optimization of hepatobiliary phase imaging in gadoxetic acid-enhanced magnetic resonance imaging: a narrative review
por: Wang, Chao, et al.
Publicado: (2023)

Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging
por: Kondo, Shota, et al.
Publicado: (2022)

Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes
por: Elkilany, Aboelyazid, et al.
Publicado: (2022)

Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer
por: Hwang, Jeong Ah, et al.
Publicado: (2022)

Portal Hypertension may Influence the Registration of Hypointensity of Small Hepatocellular Carcinoma in the Hepatobiliary Phase in Gadoxetic Acid MR
por: Caparroz, Carla, et al.
Publicado: (2022)

Correction to: Portosystemic shunt surgery in the era of TIPS: imaging‑based planning of the surgical approach
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Portosystemic shunt surgery in the era of TIPS: imaging-based planning of the surgical approach
por: Fehrenbach, Uli, et al.
Publicado: (2020)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Total Bilirubin Levels as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Pseudo-random Trajectory Scanning Suppresses Motion Artifacts on Gadoxetic Acid-enhanced Hepatobiliary-phase Magnetic Resonance Images
por: Nakamura, Yuko, et al.
Publicado: (2019)

Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article
por: Shin, Seung Kak, et al.
Publicado: (2017)

Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
por: Minamiguchi, Kiyoyuki, et al.
Publicado: (2023)

Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
por: Auer, Timo Alexander, et al.
Publicado: (2020)

Complications of cochlear implants with MRI scans in different body regions: type, frequency and impact
por: Alberalar, Nilüfer Deniz, et al.
Publicado: (2023)

Postoperative single-sequence (PoSSe) MRI: imaging work-up for CT-guided or endoscopic drainage indication of collections after hepatopancreaticobiliary surgery
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
por: Auer, Timo Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5kf3p0k91mh8cr8ntno0okoiun